Figure 3.
Survival and transplant related mortality for patients with chronic myelogenous leukemia (CML) whose clinical data were reported to the European Group for Blood and Marrow Transplantation according to risk score calculated on the basis of factors listed in Table 14. Reproduced from Gratwohl et al4 with permission of the authors and publishers.
